You just read:

Valeant Commences Cash Tender Offer For Up To $600,000,000 Outstanding Principal Amount Of Its 6.75% Senior Notes Due 2018

News provided by

Valeant Pharmaceuticals International, Inc.

Mar 07, 2017, 17:00 ET